Skip to menu Skip to content Skip to footer

A Randomised Phase II Trial of Adjuvant Avelumab in Patients with Early Stage Merkel Cell Carcinoma (2019-2027)

Experts

Emeritus Professor Mark Smithers

Emeritus Professor
Medical School
Faculty of Health, Medicine and Behavioural Sciences
Mark Smithers
Mark Smithers